Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)
Clinical trial NCT00254293 · COMPLETED
Trial details
- NCT number
- NCT00254293
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2007-05-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.